Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Persistence of Biologics in Patients with PsA in Japan; Retrospective Cohort Study Using a Claims Database (The FLYWAY Study)

NCT06600009 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT06600009
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06600009 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Persistence of Biologics in Patients with PsA in Japan; Retrospective Cohort Study Using a Claims Database (The FLYWAY Study)
Lead sponsor
Novartis
Phase
Observational
Overall status
Completed
Start date
October 17, 2022
Completion date
September 15, 2023
Enrollment
534 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriatic arthritis